Skip to content

Application of Heparin Loading Test to Heparin Anticoagulant in Critically Ill Patients with CRRT

Application of Heparin Loading Test to Heparin Anticoagulant in Critically Ill Patients with CRRT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064178
Enrollment
Unknown
Registered
2022-09-29
Start date
2022-09-30
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heparin anticoagulation in Critically Ill Patients with CRRT

Interventions

Heparin Loading Test (HLT) anticoagulation protocol:HLT protocol using the relationship between the activated partial-thromboplastin time (aPTT) after heparin loading test and the heparin maintain dos
Conventional heparin group:2500u loading dose of heparin,3ml/h maintenance dose of heparin antcoagulation

Sponsors

Dalian Municipal Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged > 18 years; 2. Heparin anticoagulation for Critically Ill Patients in CRRT; 3. Patients and/or family members agree to participate in the clinical trial and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Use of other anticoagulant drugs for 24h and/or recent (7 days) use of antiplatelet drugs; 2. High blood risk, such as active gastrointestinal ulcers, congenital or acquired bleeding abnormalities (platelet count < 50 x 10^9/L), a history of intracranial bleeding, moderate or severe stroke within the past 6 months, and major surgery or trauma within the last 30 days; 3. Patients with liver failure; 4. Have mental illness cannot cooperate; 5. Allergic to heparin or history of thrombocytopenia caused by heparin; 6. Pregnant, recently pregnant, nursing women; 7. Contraindications to anticoagulant therapy; 8. Have participated in another drug/device study or are in the follow-up period of another drug/device study. 9. The researchers concluded that there were other conditions that were not suitable for inclusion; 10. Excluded patients were those who received UFH for less than 6 hours or without an APTT at 6 hours.

Design outcomes

Primary

MeasureTime frame
Initial perfusion rate (units/kg/h);Blood clot routine;Time required to achieve threshold aPTT (h);Percentage achieving threshold aPTT;lifetimes of filters;

Countries

China

Contacts

Public ContactShan Liu

Dalian Municipal Central Hospital

liushandl@163.com+86 18604268682

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026